GPO inks medical pot research deal

GPO inks medical pot research deal

Agency sees demand being met in 3 years

The Government Pharmaceutical Organisation signs an agreement with the Department of Medical Services to cooperate in medical marijuana research and development. (Government Pharmaceutical Organisation photo)
The Government Pharmaceutical Organisation signs an agreement with the Department of Medical Services to cooperate in medical marijuana research and development. (Government Pharmaceutical Organisation photo)

The Government Pharmaceutical Organisation (GPO) has signed an agreement with the Department of Medical Services (DMS) to cooperate in medical marijuana research and development, which is expected to help boost domestic production capacity to meet demand from patients.

After the signing, the GPO said it is "confident" it will be able to produce sufficient marijuana-based medicines to meet demand within three years.

GPO's director, Dr Withoon Danwiboon, said the GPO can produce up to 10,000 five-millilitre bottles a year.

"After 2021, the agency is expecting its output to increase by eight times as we aim to scale up production from our 1,000-square-metre plantation," he said, adding that the GPO will begin to sign farm contracts with licenced growers to ensure it has access to enough raw cannabis to produce the medicines. 

"By next year, we should be able to figure out the demand in order to make an effective plan to help limit the amount of cannabis we import," Dr Withoon said.

He said the import taps must remain open at least for now because Thailand still needs to bring in cannabidiol (CBD) from abroad.

CBD is one of the active ingredients in marijuana extracts. Unlike tetrahydrocannabinol (THC) — which is responsible for marijuana's psychoactive properties — CBD has many applications in medicine.

"But most Thai marijuana strains contain more THC than CBD, which makes them more suitable for recreational use," said Dr Withoon.

The cabinet on Tuesday approved the Food and Drug Administration's (FDA) regulations on cannabis imports for medical purposes. The agency had previously said imports will continue until local supplies are sufficient to meet the growing demand.

About 50,000 patients applied for an amnesty and registered with the FDA to use marijuana for medical purposes — but only about 20% met the criteria set by the government.

Dr Somsak Akksilp, chief of the Department of Medical Services, said he wants all patients to have access to cannabis-derived drugs, so the department will cooperate with Maejo University in Chiang Mai to grow marijuana plants.

"It must be noted that for us, growing marijuana is not the end goal," said Dr Somsak. "Mainstreaming the medications so we can treat more patients is our priority."


Do you like the content of this article?
COMMENT (2)

US warns Russia against Ukraine 'aggression' as NATO meets

RIGA: The United States on Tuesday warned Russia of "serious consequences" if it launches an invasion of Ukraine, as NATO ministers looked to counter a military build-up by Moscow on its neighbour's border.

18:45

Myanmar's Suu Kyi at mercy of military once again

After a lifetime struggling against Myanmar's military, 76-year-old Nobel laureate Aung San Suu Kyi is once again at the mercy of the generals, facing charges that could land her in jail for decades.

18:32

Bengal tiger Vijit not yet found after leaving forests

A Bengal tiger that went missing after leaving forests in the Huai Kha Khaeng Wildlife Sanctuary in Uthai Thani on Nov 28 or 29 has not yet been found, but the latest signal from the animal’s collar was detected in a eucalyptus plantation in Kamphaeng Phet province.

18:24